Dexamethasone for bronchopulmonary dysplasia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Jul 2025: Trial registered, NCT07052201

The trials

NCT07052201: Dexamethasone Regimens for BPD Prevention in Preterm Infants

State
Not started
Phase
Phase 3
People
970 planned
Started
1 Feb 2026
Primary completion
31 Jan 2028
Arms
Medium-dose tapering regimen
Results
None posted
  1. 4 Jul 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Aeroseb-dex, Ciprodex component dexamethasone, Decaderm, Decadron, Decaspray, Dexa-sine, Dexacidin component dexamethasone, Dexacortal, Dexacortin, Dexamonozon, Dexapos, Dexasite, Dexasone, Dexasporin component dexamethasone, Dexone, Dextenza, Dexycu, Dexamethasone injection, Fortecortin, Hemady, Hexadrol, Isopto-dex, Loverine, Luxazone, Maxidex, Maxitrol component dexamethasone, Ozurdex, Tobradex component dexamethasone, Tobradex st component dexamethasone.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.